Cargando…
BACE-1 inhibition prevents the γ-secretase inhibitor evoked Aβ rise in human neuroblastoma SH-SY5Y cells
BACKGROUND: Accumulation of amyloid β-peptide (Aβ) in the plaques is one of the major pathological features in Alzheimer's disease (AD). Sequential cleavage of amyloid precursor protein (APP) by β-site APP cleaving enzyme 1 (BACE-1) and γ-secretase results in the formation of Aβ peptides. Preve...
Autores principales: | Jämsä, Anne, Belda, Oscar, Edlund, Michael, Lindström, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217850/ https://www.ncbi.nlm.nih.gov/pubmed/22018341 http://dx.doi.org/10.1186/1423-0127-18-76 |
Ejemplares similares
-
BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
por: Maia, Miguel A., et al.
Publicado: (2019) -
The Alzheimer's disease β-secretase enzyme, BACE1
por: Cole, Sarah L, et al.
Publicado: (2007) -
BACE1: More than just a β‐secretase
por: Taylor, Hannah A., et al.
Publicado: (2022) -
Gram-Scale Synthesis of a β-Secretase
1 (BACE 1) Inhibitor
por: Allison, Brett D., et al.
Publicado: (2017) -
Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels
por: Youn, Kumju, et al.
Publicado: (2017)